Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Blood-based tumor mutational burden as a predictor of cli... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
0
Authors
David Gandara
25 more
David Gandara
•
Todd Riehl
23 more
•
David Shames
Published
July 30, 2018
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Internal Medicine
Show all topics
DOI
10.1038/s41591-018-0134-3
